EDGAR Filing Documents for 0001564590-22-029481

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-22-029481

Filing Date

2022-08-15

Accepted

2022-08-15 15:45:55

Documents

Period of Report

2022-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	emma-10q_20220630.htm iXBRL	10-Q	3076489
2	EX-31.1	emma-ex311_8.htm	EX-31.1	9934
3	EX-31.2	emma-ex312_7.htm	EX-31.2	10012
4	EX-32.1	emma-ex321_9.htm	EX-32.1	7811
	Complete submission text file	0001564590-22-029481.txt		14088717

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA	emma-20220630.xsd	EX-101.SCH	77603
6	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	emma-20220630_cal.xml	EX-101.CAL	70887
7	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	emma-20220630_def.xml	EX-101.DEF	295145
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	emma-20220630_lab.xml	EX-101.LAB	559296
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	emma-20220630_pre.xml	EX-101.PRE	472367
76	EXTRACTED XBRL INSTANCE DOCUMENT	emma-10q_20220630_htm.xml	XML	3653750

Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503

Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065

Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)